Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

News

News YahooFinance 2 years ago
What To Expect From Calliditas Therapeutics AB (OSTO:CALTX) Q3 2024 Earnings
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Read more
Report
News Nasdaq 2 years ago
Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know
In the last three months, 5 analysts have published ratings on Calliditas Therapeutics (NASDAQ:CALT), offering a diverse range of perspectives from bullish to bearish.The table below offers a condensed view of their recent ratings, showcasing the ...
Read more
Report
News The Motley Fool 3 years ago
Calliditas Therapeutics Ab (publ) - CALT - Stock Price & News
Real time Calliditas Therapeutics Ab (publ) (CALT) stock price quote, stock graph, news & analysis.
Read more
Report
Press release Nasdaq 5 years ago
Calliditas Therapeutics to Host Key Opinion Leader Perspectives Webinar on the Pathophysiology and Treatment of IgA Nephropathy in Clinical Practice
--Calliditas Therapeutics AB today announced that it will host a Key Opinion Leader Perspectives webinar on the Pathophysiology and Treatment of IgA Nephropathy in Clinical Practice on Wednesday, March 10, 2021 at 10:00am Eastern Time.. The webinar will f
Read more
Report